Lipocalins and insulin resistance: etiological role of retinol-binding protein 4 and lipocalin-2?
van Dam
Rob M
RM
Hu
Frank B
FB
D000209:Acute-Phase Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D015992:Body Mass Index; D002097:C-Reactive Protein / Q000032:analysis; D006801:Humans; D007249:Inflammation / Q000378:metabolism; D007333:Insulin Resistance; D000071068:Lipocalin-2; D054834:Lipocalins; D008099:Liver / Q000378:metabolism; D051379:Mice; D008820:Mice, Obese; D009765:Obesity / Q000097:blood / Q000209:etiology; D015513:Oncogene Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000097:blood*; D047495:PPAR gamma / Q000819:agonists; D011518:Proto-Oncogene Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000097:blood*; D012177:Retinol-Binding Proteins / Q000378:metabolism*; D054839:Retinol-Binding Proteins, Plasma; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000494:pharmacology
D000209:Acute-Phase Proteins; C489506:LCN2 protein, human; D000071068:Lipocalin-2; D054834:Lipocalins; D015513:Oncogene Proteins; D047495:PPAR gamma; D011518:Proto-Oncogene Proteins; C101326:RBP4 protein, human; D012177:Retinol-Binding Proteins; D054839:Retinol-Binding Proteins, Plasma; D045162:Thiazolidinediones; D000077154:Rosiglitazone; C071332:Lcn2 protein, mouse; D002097:C-Reactive Protein